News
EUSAAT Summary of latest technologies
⭐️ Did you miss the EUSAAT congress last month? 👀 If you did, here is your chance to catch up! Check out this insightful summary of the latest technologies and research to replace animals shown during the congress. 🙏 Thanks Menschen Für Tierrechte for the highlight.
Read now
FDA Modernization Act 2.0 has passed the US Senate
📢 As of Sept 29, the FDA Modernization Act 2.0 has passed the US Senate. 💡This bill marks a turning point in how animal testing is seen in drug development.  By stating that innovative technologies such as Organs-on-Chip and microphysiological systems can be used to evaluate drug safety and efficacy, the bill enables relevant validated...
Read now
Open letter for the FDA Modernization Act
🤔 Since 1938, the FDA has required that all drugs need to be tested in animal models prior to clinical trials. However, science and technology have advanced considerably in the past years. So, it is time to change! 💪 At AlveoliX we support the initiative of the FDA Modernization Act to recognize and implement legally...
Read now
AlveoliX is part of the 2022 Lush Prize shortlist
📢 Find out who is in the running for the 2022 Lush Prize! 🏅 We are very excited to have made it to the Shortlist among many great applicants with our project “A barrier-on-chip with integrated 3D stretching: an alternative predictive tool to support decision making”. 🤞 Let’s keep our fingers crossed! See you at...
Read now
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Please find more information in our privacy policy

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

This website uses HubSpot to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.